Author

Jane Frimodig

University of Louisville - Cited by 105 - TIMP-1 - liver ischemia reperfusion - cancer stem cells - stem cell encapsulation

Biography

Jane Frimodig is currently working as a Department of Pharmacology, University of Louisville, USA; he extended his valuable service in field of Pharmacology and Toxicology for several years and has been a recipient of few awards and grants. His research interests reflect in his wide range of publications in various national and international journals.
Title
Cited by
Year
Calculation of shrinkage compensation factors for rapid prototyping (FDM 1650)
Q Dao, JC Frimodig, HN Le, XZ Li, SB Putnam, K Golda, J Foyos, ...Computer Applications in engineering education 7 (3), 186-195, 1999199
41
1999
Dysregulation in plasma ω3 fatty acids concentration and serum zinc in heavy alcohol-drinking HCV patients
V Vatsalya, R Agrawal, J Frimodig, S Srivastava, ML SchwandtAdvances in Virology 2020, 2020202
4
2020
Liver injury assessment by vetscan VS2 analyzer and most frequently used ALT/GTP reagent
V Vatsalya, D Avila, JC Frimodig, SS Barve, CJ McClain, L GobejishviliGastroenterology & hepatology (Bartlesville, Okla.) (), 2016201
4
2016
3
2021
Encapsulation of Stem Cells in Research and Therapy
IS Hueck, J Frimodig, P Itkin-Ansari, DA GoughBiological, Physical and Technical Basics of Cell Engineering, 29-69, 2018201
3
2018
411–Phosphodiesterase 4 Inhibitor Rolipram Inhibits Neutrophil Recruitment in Liver Ischemia Reperfusion Injury by Mechanisms Not Obviously Dependent on Cytokines/Chemokines
4–Phosphodiesterase 4 Inhibitor Rolipram Inhibits Neutrophil Recruitment in Liver Ischemia Reperfusion Injury by Mechanisms Not Obviously Dependent on Cytokines/ChemokinesJ Frimodig, PJ Matheson, A Matheson, CJ McClainGastroenterology 56 (6), S-97-S-98, 20920
1
2019
The Potential of Selectively Cultured Adult Stem Cells Re-implanted in Tissues
IS Hueck, M Haas, R Finones, J Frimodig, DA GoughStem cell engineering: Principles and applications, 79-7, 202
1
2011
Angiogenic potential of prostate tumor stem cells
JC FrimodigUniversity of California, San Diego, 20020
1
2010